• Cardiol Therapeutics held its annual general meeting on June 24, 2026.
• Shareholders adopted the slate of directors for the ensuing year.
• BDO Canada was appointed auditor for the next fiscal year; directors were authorized to set auditor remuneration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiol Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606250727PR_NEWS_USPR_____TO91962) on June 25, 2026, and is solely responsible for the information contained therein.